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Abstract
Objective—To test the a priori hypothesis that acute and chronic work exposures to the World 
Trade Center (WTC) site on or after September 11, 2001 were associated with risk of new-onset 
systemic autoimmune diseases.
Methods—A nested case–control study was performed in WTC rescue/recovery workers who 
had received a rheumatologist-confirmed systemic auto-immune disease diagnosis between 
September 12, 2001 and September 11, 2013 (n = 59), each of whom was individually matched to 
4 randomly selected controls (n = 236) on the basis of year of hire (±1 year), sex, race, and work 
assignment (firefighter or emergency medical service). Acute exposure was defined according to 
the earliest time of arrival (morning of 9/11 versus later) at the WTC site, and chronic exposure 
was defined as duration (number of months) of WTC site–related work. Rheumatologists were 
blinded with regard to each subject’s exposure status. The conditional odds ratios (CORs) with 
95% confidence intervals (95% CIs) for incident autoimmune disease were derived from exact 
conditional logistic regression models.
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Results—Rheumatoid arthritis was the most common autoimmune diagnosis (37% of subjects), 
followed by spondyloarthritis (22%), inflammatory myositis (14%), systemic lupus erythematosus 
(12%), systemic sclerosis (5%), Sjogren’s syndrome (5%), antiphospholipid syndrome (3%), and 
granulomatosis with polyangiitis (Wegener’s) (2%). The COR for incident autoimmune disease 
increased by 13% (COR 1.13, 95% CI 1.02–1.26) for each additional month worked at the WTC 
site. These odds were independent of the association between high acute exposure (working during 
the morning of 9/11) and disease outcome, which conveyed an elevated, but not statistically 
significant, risk (COR 1.85, 95% CI 0.86–3.89).
Conclusion—Prolonged work at the WTC site, independent of acute exposure, was an important 
predictor of post-9/11 systemic autoimmune diseases. The WTC Health Program should expand 
surveillance efforts for those with extended exposures, as early detection can facilitate early 
treatment, which has been shown to minimize organ damage and improve quality of life.
Genetic factors are known to influence the development of autoimmune diseases, although 
heritability studies using identical twins suggest only low-to-moderate concordance rates 
(1), depending on the disease, implying that environmental, occupational, or other factors 
also play an important role in disease development. Compared with the growing body of 
genetic research, fewer resources have been allocated to studying environmental/
occupational exposures. One well-studied environmental exposure is silica, a basic 
component of soil, sand, granite, and many other minerals, which has been associated with 
rheumatoid arthritis (RA) (2), systemic sclerosis (3,4), systemic lupus erythematosus (5), 
dermatomyositis (1), Sjogren’s syndrome (6), and risk of antineutrophil cytoplasmic 
antibody–associated vasculitis (7). Autoimmune diseases have also been associated with 
environmental exposures to metals, ozone, hydrocarbons, organic solvents, pesticides, and 
particulates, and cigarette smoking has been shown to increase the formation of 
autoantibodies (8–11). In general, these autoimmune conditions were found to be associated 
with chronic environmental exposures acquired over years or even decades, presumably in 
individuals with genetic predispositions.
The terrorist attacks on the World Trade Center (WTC) buildings and the subsequent 
building collapses and fires on September 11, 2001 exposed rescue/recovery workers and 
residents to aerosolized WTC dust—an amalgam of pulverized cement, glass fibers, silica, 
asbestos, lead, polycyclic aromatic hydrocarbons, polychlorinated biphenyls, and 
polychlorinated furans and dioxins (12). While it is widely known that most of the Fire 
Department of the City of New York (FDNY) workforce of firefighters and emergency 
medical service (EMS) workers arrived at the disaster site within days or even hours of the 
9/11 attacks, it may be less well known that many continued to work at the site for up to 10 
months, potentially experiencing chronic exposures to resuspended particulate matter. 
Evidence of the effects of these intense WTC work site exposures, both acute and chronic, is 
abundant, as more than 70% of FDNY workers reported experiencing one or more 
respiratory and aerodigestive symptoms in the first year post-9/11, which, over time, led to 
physician-diagnosed chronic conditions, including asthma, chronic bronchitis, rhinosinusitis, 
gastroesophageal reflux disease, and cancer (13,14). We have also documented dramatic 
post-9/11 declines in lung function, consistent with the increased incidence of these 
respiratory conditions (15,16).
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The full spectrum of the health consequences of exposure to the WTC disaster site remains 
unknown. The FDNY-WTC Health Program has been following up a cohort of nearly 16,000 
firefighters and EMS workers who worked at the WTC site. Clinical observations of 
systemic autoimmune diseases in these workers (mostly male) triggered a preliminary 
medical records review. The current nested case–control study was designed to assess 
whether acute or chronic work exposures to the WTC site on or after 9/11 were associated 
with incident systemic autoimmune diseases, including systemic lupus erythematosus, 
antiphospholipid syndrome, systemic sclerosis, inflammatory myositis, Sjogren’s syndrome, 
RA, spondyloarthritis, granulomatosis with polyangiitis (Wegener’s), and eosinophilic 
granulomatosis with polyangiitis (Churg-Strauss).
SUBJECTS AND METHODS
Data sources
We obtained information on each subject’s race, sex, and FDNY hire date from FDNY 
employee databases. In addition, self-administered health questionnaires were used to obtain 
information on smoking status, symptoms of posttraumatic stress disorder (PTSD), and 
acute and chronic WTC site–related exposures. We also obtained case records on 
rheumatologist-confirmed diagnoses of systemic autoimmune diseases.
Health questionnaires
Cigarette smoking was characterized as “ever” versus “never” by combining current and 
former smokers into a single “ever” category. Smoking status was identified from each 
participant’s most recent questionnaire. The earliest questionnaire date was 2008, the most 
recent was 2014, and the median was 2013. Symptoms of PTSD were assessed using the 17-
item PTSD Checklist, Civilian Version (17), which, since 2005, is routinely administered as 
part of the mental health questionnaire. We considered symptoms of PTSD as present if the 
participant attained a total score of ≥44 and reported experiencing symptoms in each of 3 
domains (reexperiencing, avoidance, and hyperarousal) (18). PTSD status was identified 
from each participant’s first mental health questionnaire. The earliest questionnaire date was 
2006, the most recent was 2014, and the median was 2007.
Exposure ascertainment
Measures of WTC site exposure were defined as acute or chronic. Acute exposure was based 
on the earliest time of arrival at the WTC site, as reported by each individual on the first 
post-9/11 health questionnaire, which was administered starting in October 2001. We 
categorized arrival time into 2 groups: arriving on the morning of 9/11 versus arriving any 
time thereafter until July 25, 2002 (19), when the site was closed to FDNY workers. 
Questions about chronic exposure, or duration of work, were added to the monitoring 
questionnaires in 2002. Members were asked to indicate the months in which they worked at 
least 1 day at the WTC site. Duration was then measured by summing the number of months 
a member worked between September 11, 2001 and July 25, 2002 (20). Since all of the 
study participants had reported working at the WTC site, the minimum exposure duration 
was 1 month.
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The FDNY-WTC Health Program schedules monitoring evaluations of active and retired 
individuals from the WTC site–exposed workforce every 12 to 18 months. The monitoring 
visit includes a physical examination and completion of self-administered physical and 
mental health questionnaires. In 2005, we amended the physical health questionnaire to 
include a question about doctor-diagnosed autoimmune disease and, in 2009, created an 
auto-immune registry to capture potential cases of new-onset systemic autoimmune disease 
in 2 ways. Most commonly, potential cases are self-reported in the physical health 
questionnaires, which is specifically addressed by one question: “Since your last FDNY 
WTC annual medical, has a doctor or health professional told you that you have arthritis or 
any autoimmune disease listed below?” Answer choices include “rheumatoid arthritis,” 
“lupus,” “polymyositis/dermatomyositis,” and “other (for example, psoriatic arthritis or 
scleroderma).” Individuals are not limited to one response. Additionally, the registry is 
populated by potential cases of systemic autoimmune disease self-reported by a patient to an 
FDNY physician either during a medical monitoring examination or during a treatment visit. 
This information is recorded as part of the patient’s medical history.
The registry clinician (NJ) contacts every individual in the autoimmune registry considered 
to potentially have a systemic autoimmune disease. During the study period, there were 738 
potential cases of self-reported systemic autoimmune diseases. After a brief telephone call, 
522 cases (71%) were determined to be “reporting errors,” mostly involving individuals who 
had osteoarthritis and not RA. Of the 216 possible cases (i.e., not reporting errors), we were 
unable to contact 59 of these individuals, either by telephone or mail, and 72 were contacted 
and determined to be “possible cases,” but they failed to submit adequate documentation by 
the study close. The final population consisted of 59 medically confirmed cases of a 
systemic autoimmune disease, 51 cases of a systemic autoimmune disease originating from 
the annual monitoring questionnaires, and 8 additional cases of a systemic autoimmune 
disease originating from the FDNY physician notes.
Medically confirmed cases required diagnostic documentation from the treating physician/
rheumatologist. Documentation from the treating rheumatologist had to include the specific 
systemic autoimmune disease diagnosis and the approximate diagnosis date (month and 
year). If there was any supporting laboratory work, imaging, pathologic findings, or relevant 
treatment notes, we asked that it also be sent to the registry clinician for review. Before final 
confirmation, all cases were re-reviewed by our systemic autoimmune disease case 
consultation group, which included 2 rheumatologists (JB and BQ) who were blinded with 
regard to each subject’s history of WTC site exposure. Unanimous agreement was required 
for confirmation. Only confirmed cases were used for the analyses.
The at-risk population consisted of 15,484 WTC site–exposed firefighters and EMS workers. 
Inclusion criteria were as follows: having completed a monitoring questionnaire during or 
after 2005, thereby having had the potential to self-report, not having a pre-9/11 systemic 
autoimmune disease diagnosis, not having an unconfirmed systemic autoimmune disease 
diagnosis in the autoimmune registry, having known exposure to the WTC site (known time 
and date of first arrival and number of months worked at the WTC site), having a working 
telephone number, and having provided written consent for research. After exclusion of 
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subjects who did not meet these criteria, the study population comprised 13,617 subjects 
(87.9%).
For the current analysis, post-9/11 diagnoses of interest included rheumatologist-confirmed 
diagnoses of any of the following systemic autoimmune diseases: systemic lupus 
erythematosus, antiphospholipid syndrome, systemic sclerosis (both diffuse and limited), 
inflammatory myositis (dermatomyositis, polymyositis, or inclusion-body myositis), 
Sjogren’s syndrome, RA, spondyloarthritis (i.e., psoriatic arthritis and ankylosing 
spondylitis), granulomatosis with polyangiitis (Wegener’s), and eosinophilic granulomatosis 
with polyangiitis (Churg-Strauss). All diagnoses met the American College of 
Rheumatology classification criteria (21–27). In the primary analyses, all systemic 
autoimmune disease diagnoses were combined as a single outcome of interest. In additional 
analyses, the systemic autoimmune disease with the greatest incidence, RA, was used as the 
outcome of interest.
We accrued cases of systemic autoimmune diseases diagnosed between September 12, 2001 
and September 11, 2013. After accrual was closed, we randomly selected 4 matched controls 
for each case using incidence density sampling, based on the following criteria: year of 
FDNY hire (within 1 year), sex, race, and work assignment (firefighter or EMS). We did not 
base the matching on age, because, in this cohort, age and year of hire are highly correlated 
(r = 0.91). Potential controls were contacted by the registry clinician to verify their noncase 
status as of 2 years prior to the diagnosis date of their matched case (28). Consistent with 
incidence density sampling, controls were eligible to become a case at a later date and could 
also serve as a control for more than one case.
This study has been approved by the institutional review board at Montefiore Medical 
Center, Bronx, New York and is in compliance with the Declaration of Helsinki.
Statistical analysis
Preliminary analyses included examination of demographic features and other 
characteristics, including acute and chronic exposure, by case or control status. Acute 
exposure (arrival time) was categorized as arriving on the morning of 9/11 versus arriving 
any time thereafter up to the time of worksite closure. Chronic exposure (duration of work) 
was treated as a continuous variable (per month) and was also grouped dichotomously into 
high chronic exposure versus low chronic exposure based on the median number of months 
worked (the median split). For univariable and multivariable analyses, we constructed exact 
conditional logistic regression models for determining the odds of incident systemic 
autoimmune disease, while separate models were constructed to determine the odds of a 
diagnosis of RA, the most common individual diagnosis. The exact method was appropriate, 
given our small sample size (29). The primary predictors of interest were acute and chronic 
WTC site exposure, but based on factors suggested in the literature, we also examined the 
possible effects of smoking history (ever versus never) (8) and PTSD symptoms (present 
versus absent) (30) on the systemic autoimmune disease outcome, and separately, on the RA 
outcome. Conditional odds ratios (CORs) with 95% confidence intervals (95% CIs) were 
derived from these conditional logistic regression models.
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To adjust for possible disease latency, we performed a sensitivity analysis using an exact 
conditional logistic model in which we removed the 5 strata (cases and matched controls) 
with cases that had been diagnosed within 2 years of 9/11. Similarly, for the model 
predicting RA, we carried out a sensitivity analysis in which we removed the 3 strata with 
cases that had been diagnosed within 2 years of 9/11.
All analyses were performed using SAS statistical software (version 9.4). P values less than 
or equal to 0.05 were considered statistically significant.
RESULTS
Overall, we confirmed 59 cases of systemic auto-immune diseases. The most common 
individual diagnosis was RA (22 cases [37.3%]). The number of diagnoses increased after 
2004, peaking between 2005 and 2010 (Table 1). Most cases (56 [94.9%] of 59) occurred in 
men. Characteristics of the cases and controls are displayed in Table 2.
Ascertainment of exposure, both acute and chronic, usually occurred well before diagnosis. 
The median time between ascertainment of time of arrival at the WTC site, as obtained from 
the monitoring questionnaire, and diagnosis of a systemic autoimmune disease was 5 years. 
The median time between ascertainment of duration of work exposure, as obtained from the 
monitoring questionnaire, and diagnosis of a systemic autoimmune disease was 3 years, 
because duration-related questions were a later addition to our monitoring program. In all 
final models, cases of systemic autoimmune disease were significantly more likely than 
controls to have reported prolonged work exposure to the WTC site (Table 3).
Using duration of work exposure as a continuous variable, the COR for incident systemic 
autoimmune disease was 1.13 (95% CI 1.02–1.26), representing a 13% increase in odds for 
each month worked at the WTC site. As a dichotomous variable (median split at 2 months’ 
duration), the COR for duration of exposure was 2.40 (95% CI 1.16–5.23). Results were 
similar in models in which we removed all cases reported by EMS workers (n = 5) and their 
matched controls (n = 20) (data not shown).
In the sensitivity analysis adjusting for potential disease latency, we removed 5 strata with 
cases diagnosed within 2 years of 9/11. The effect of duration of exposure (as a continuous 
variable) on the risk of a systemic autoimmune disease increased to 17% per month (COR 
1.17, 95% CI 1.05–1.31), and similarly increased when we used a median split for duration 
of work at the site (COR 3.11, 95% CI 1.40–7.51) (Table 3).
We also examined the effects of acute exposure to the WTC site and found that individuals 
subsequently diagnosed as having a systemic autoimmune disease were somewhat more 
likely to have arrived at the WTC site during the morning of 9/11, although the effect of 
early arrival was not statistically significant in either the univariable models (COR 1.85, 
95% CI 0.86–3.89) or multivariable models. In a model with a term controlling for duration 
of exposure, the effect of arriving at the WTC site during the morning of 9/11 was similar to 
that in the model without adjustment for duration (COR 1.80, 95% CI 0.84–3.80). In the 
model including both chronic exposure (duration of work exposure as a continuous variable) 
and acute exposure (time of arrival at the WTC worksite), the COR was 1.13 (95% CI 1.02–
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1.26) for each additional month worked at the site. There was no interaction between acute 
exposure and duration of exposure.
Neither of the other potential correlates (smoking status [ever versus never] or PTSD 
symptoms [presence versus absence]) was associated with new-onset systemic autoimmune 
diseases in this cohort. Models using RA as the outcome showed that the CORs for 
associations with acute and chronic exposures, smoking, and PTSD symptoms were similar 
to those found in the model combining all systemic autoimmune diseases as the outcome, 
although no factors attained statistical significance at the 0.05 level (data not shown), 
perhaps due to low power.
DISCUSSION
This study examining the incidence of post-9/11 systemic autoimmune diseases in WTC 
rescue/recovery workers is the first to demonstrate a strong independent effect of prolonged 
work at the WTC disaster site on the incidence of systemic autoimmune diseases. The effect 
of chronic exposure increased by ~13% for each month worked at the WTC site. Based on 
this model, for those who worked the full 10 months compared with those who worked for 1 
month, we estimate the COR for incident systemic autoimmune disease as 3.09 (95% CI 
1.21–7.94). When we modeled duration of exposure using a median split, those who worked 
at least 2 months at the site incurred a risk more than double that of workers who worked 
fewer than 2 months. These results are consistent with non–WTC-related studies of chronic 
occupational exposures and disease outcomes. For example, silicosis usually takes at least 
10 years after exposure to develop, but may develop sooner after a large exposure (31). To 
the best of our knowledge, previous studies have demonstrated an association of acute and 
chronic WTC site exposures with respiratory conditions such as asthma (20,32,33) and 
PTSD (34–36), but not with the new onset of systemic autoimmune diseases, other than 
sarcoidosis (37–39).
The cause or causes of systemic autoimmune diseases are unknown and likely multifactorial. 
One common hypothesis postulates that a series of events are responsible for the initiation of 
an autoimmune reaction. Genetic susceptibility may be the crucial first factor. Next, an 
antigenic event such as an infection or environmental exposure occurs, and then, through 
various immunologic–inflammatory–oxidative pathways, an autoimmune response occurs, 
ultimately leading to clinical symptoms and disease. Just as genetic susceptibility may 
involve multiple genetic risk factors, the triggering event may also involve multiple 
environmental factors or multiple factors at different periods or in a specific time sequence 
(8).
The systemic autoimmune diseases included in this study have diverse immunogenetic 
inflammatory mechanisms, but they all can lead to uncontrolled inflammation, pain, 
disability, and, often, tissue destruction (40,41). Many components of adaptive and innate 
immunity come into play in each of these diseases and any attempt to group them by 
pathophysiology seems problematic. More work is needed to correctly define the dominant 
pathways for each disease. We excluded sarcoidosis, since we have previously reported that 
the incidence of sarcoidosis, primarily involving intrathoracic disease, increased after WTC 
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site exposure in FDNY firefighters and EMS workers (38). A high point prevalence was 
similarly reported in 2 other WTC site–exposed cohorts (37,42), and 2 case series described 
WTC workers with sarcoid arthropathies (43,44). We included diagnoses of granulomatosis 
with polyangiitis (Wegener’s) and eosinophilic granulomatosis with poly-angiitis (Churg-
Strauss) in our analyses, but no cases of the latter were found. In the future, as we begin to 
understand more about the different parts of the immune system that contribute to these 
various diseases, further subgroupings may be possible. Until then, however, attempts to 
force categorization may not only be premature, but also misleading, because they will fail 
to capture the complexity of the underlying disease mechanisms.
We are confident in the results of the current study for several reasons. First, our cohort 
existed prior to 9/11, eliminating recruitment bias. Second, although self-reported physician 
diagnoses usually started the documentation process, all individuals in the cohort had the 
opportunity to report diagnoses on their monitoring questionnaires, which were then 
confirmed by our rheumatology case consultation review panel. Third, it is unlikely that 
members of our cohort had unrecognized pre-9/11 systemic autoimmune diseases, because 
the physical demands of firefighting and EMS work would have made concealment difficult. 
Fourth, we examined possible lack of bioplausibility by carrying out sensitivity analyses, 
removing those diagnosed within 2 years of 9/11, and found similar results, despite lower 
statistical power. Fifth, we believe that our control subjects were truly nondiseased, as they 
were selected on the basis of the absence of self-reported and physician diagnoses of 
systemic autoimmune diseases in our electronic medical records database. Each control was 
then contacted to confirm his or her nondisease status as of 2 years prior to the case 
diagnosis date, which thereby rules out the possibility of misclassification of disease 
outcomes in the control population. Finally, information about WTC site exposures was 
collected from questionnaires completed by all cohort members regardless of symptoms. In 
most cases, this information was obtained years prior to the date of diagnosis, which is 
evidence against the possibility of recall bias, or differential recall of WTC site exposure 
among affected individuals.
Our findings have important clinical implications for the estimated 409,000 WTC site–
exposed workers and residents (45), of whom ~120,000 have already enrolled in WTC 
Health Programs at the FDNY, the WTC Responder Health Consortium, or the WTC Health 
Registry at the New York City Department of Health and Mental Hygiene. Autoimmune 
diseases in North American and European populations have been thought to predominantly 
affect women (>75% of cases). Since the FDNY workers are predominantly men (96%), and 
the other WTC worker populations are also predominantly composed of men (78% at the 
WTC Health Registry [46] and 87% at the WTC Health Program Consortium [47]), our 
findings are unexpected and highlight the need for increased clinician awareness of the 
possibility of these, and perhaps other, autoimmune disorders in their WTC site–exposed 
male patients.
Our findings also reveal the lack of comparison rates of autoimmune disorders in various 
non–WTC site–exposed populations, specifically in men. Population-based prevalence 
studies have been inconsistent in their methods and have reported varying results. For 
example, 2 meta-analyses indirectly estimated population rates of autoimmune disorders by 
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comprehensively reviewing the published literature and applying rates in samples to the US 
population (48,49), although neither included estimates by sex. In 1997, Jacobson et al 
reported the total population prevalence of 19 autoimmune diseases in the US as 1 in 31 (or 
3.2%) (49). In 2009, Cooper et al estimated the total population prevalence of 29 
autoimmune diseases, which differed from the diseases included in the Jacobson study, as 
7.6–9.4% (50). Both studies estimated the incidence of autoimmune diseases as <0.5% per 
year (48,49). Incidence rates as estimated from other populations, both in the US and 
abroad, however, may not be applicable to specific populations such as our cohort, which is 
composed mostly of healthy white men. Our nested case–control study takes on added 
significance for this very reason.
A limitation of our study is that it involved a relatively small sample size with a largely 
white, male population. However, since we matched cases and controls on the basis of these 
characteristics, this limitation should not have affected our primary goal of estimating the 
association between WTC site exposure (whether acute or chronic) and systemic 
autoimmune diseases. Each case was randomly matched to 4 controls based on sex, race, 
work assignment, and hire year, so that cases and controls had similar levels of training, 
access to personal protective equipment, and work exposures throughout their careers. We 
did not match on the basis of age, as in previous studies we found that matching on year of 
hire was sufficient to control for age, a decision supported by the median age of the cases 
and controls at the conclusion of the study (median 57.2 years versus 56.4 years). Thus, we 
are confident that our findings are not the result of confounding by smoking status, PTSD, or 
other known factors, but rather describe the effects of acute and chronic work exposure to 
the WTC site.
We cannot, however, rule out the possibility that confounding by unknown and unmeasured 
factors could have influenced our study results. For example, our duration variable does not 
differentiate between those with 1 day of exposure and those with many days of exposure in 
a given month. We also note that in the mid-portion of this study period, the number of cases 
diagnosed increased. We cannot determine whether this was attributable to a biologic effect 
or to increased awareness. Regardless, these factors should have had a similar impact on our 
controls. In addition, case ascertainment may have been incomplete after 2010, as there was 
a time lag of ~2 years between receiving a systemic autoimmune disease diagnosis and 
having the opportunity to self-report the diagnosis on the medical monitoring questionnaire. 
Finally, other study limitations include the lack of information about family history of 
systemic autoimmune diseases and about non–WTC site–related exposures, both work-
related and recreational.
Systemic autoimmune diseases are relatively rare, but their adverse effects in terms of 
disability and activity limitation are great. This is the first study of WTC site–related 
systemic autoimmune diseases. We found a strong association between prolonged work at 
the WTC disaster site, such that the odds of systemic autoimmune diseases increased by 
~13% for each month at the site, or more than 3-fold for those who worked at the site for the 
full 10 months’ duration. Accordingly, we suggest enhanced surveillance of WTC site–
exposed worker and resident cohorts to further assess our findings and to provide early 
access to care. The stakes are high because enhanced surveillance can lead to early detection 
Webber et al. Page 9













and treatment of systemic autoimmune diseases, which has been shown to improve quality 
of life and reduce or delay organ damage, including amelioration of erosive joint destruction, 
kidney failure, pulmonary fibrosis, and hypertension (40,41).
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Table 1
Distribution and year of systemic autoimmune disease diagnoses in the case cohort (n = 59)*
Type of systemic autoimmune disease
 Rheumatoid arthritis 22 (37.3)
 Spondyloarthritis 13 (22.0)
  Psoriatic arthritis 11 (18.6)
  Reactive arthritis 1 (1.7)
  Spondyloarthritis (axial and peripheral, without ankylosis) 1 (1.7)
 Inflammatory myositis 8 (13.6)
  Polymyositis 6 (10.2)
  Dermatomyositis 2 (3.4)
 Systemic lupus erythematosus 7 (11.9)
 Systemic sclerosis (scleroderma) 3 (5.1)
 Sjogren’s syndrome 3 (5.1)
 Antiphospholipid syndrome 2 (3.4)
 Granulomatosis with polyangiitis (Wegener’s) 1 (1.7)
 Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 0 (0.0)
Year of diagnosis
 2002–2004 10 (16.9)
 2005–2007 19 (32.2)
 2008–2010 17 (28.8)
 2011–2013† 13 (22.0)
*
Values are the number (%) of subjects. Due to rounding, percentages do not add up to 100%.
†
Case ascertainment may be incomplete for this time period.
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Table 2
Characteristics of systemic autoimmune disease cases and nondisease controls*
Cases (n = 59) Controls (n = 236) Total (n = 295)
Race
 White 56 (94.9) 224 (94.9) 280
 Hispanic 3 (5.1) 12 (5.1) 15
 African American 0 (0.0) 0 (0.0) 0
 Asian 0 (0.0) 0 (0.0) 0
 Other 0 (0.0) 0 (0.0) 0
Sex
 Male 56 (94.9) 224 (94.9) 280
 Female 3 (5.1) 12 (5.1) 15
Work assignment
 Firefighter 54 (91.5) 216 (91.5) 270
 EMS 5 (8.5) 20 (8.5) 25
Age, median (range) years
 At hire 26.9 (21–36.1) 26.5 (19–36.3)
 At diagnosis of case 50.4 (28.4–69.4) 50.2 (26.8–71.6)
 On September 11, 2013 57.2 (36.7–75.9) 56.4 (34.3–78.0)
Chronic exposure
 High (≥2 months on site) 43 (72.9) 132 (55.9) 175
 Low (1 month on site) 16 (27.1) 104 (44.1) 120
Acute exposure
 Morning arrival on September 11, 2001 16 (27.1) 41 (17.4) 57
 Later arrival 43 (72.9) 195 (82.6) 238
*
Except where indicated otherwise, values are the number (%) of subjects. EMS = emergency medical service.













Webber et al. Page 15
Table 3
Final exact conditional logistic regression models assessing associations between the duration of WTC site 
exposure and risk of any systemic autoimmune diseases*
Risk of systemic autoimmune diseases
Model
Duration as continuous variable (per 
month)
Duration as dichotomous variable 
(median split)
Primary model
 Duration of WTC site work 1.13 (1.02–1.26) 2.40 (1.16–5.23)
Secondary models
 Tobacco history
  Duration of WTC site work 1.14 (1.02–1.27) 2.42 (1.17–5.28)
  Cigarette smoking history (ever vs. never) 1.16 (0.62–2.20) 1.13 (0.60–2.12)
 PTSD
  Duration of WTC site work 1.13 (1.02–1.25) 2.38 (1.15–5.20)
  PTSD symptoms (presence vs. absence) 1.40 (0.58–3.14) 1.47 (0.61–3.30)
Sensitivity analysis
 Duration of WTC site work† 1.17 (1.05–1.31) 3.11 (1.40–7.51)
*
Values are the exact conditional odds ratio (95% confidence interval). WTC = World Trade Center; PTSD = posttraumatic stress disorder.
†
For sensitivity analyses, 5 strata with cases diagnosed between September 12, 2001 and September 11, 2003 (within 2 years of 9/11) were 
removed. A total of 54 strata remained in the model.
Arthritis Rheumatol. Author manuscript; available in PMC 2017 August 18.
